PTPN11 and cancer: A key finding of this work is that sensitization to inhibition of the MEK/ERK cascade can be achieved in cancer cells through mechanisms that rely on SHP2-controlled production of vascular factors, increased cell clustering, and increased dependence on nutrients and oxygen for cell survival.